The Effect of Polymorphisms and Other Biomarkers on Infliximab Exposure in Paediatric Inflammatory Bowel Disease: Development of a Population Pharmacokinetic Model.

Published in:

Pediatric Drugs, 2024, v. 26, n. 3, p. 331, doi. 10.1007/s40272-024-00621-1

By:

• Clemente-Bautista, Susana;
• Trocóniz, Iñaki F.;
• Segarra-Cantón, Óscar;
• Salvador-Marín, Sara;
• Parramón-Teixidó, Carlos J.;
• Álvarez-Beltrán, Marina;
• López-Fernández, Luís A.;
• Colom, Helena;
• Cabañas-Poy, Maria J.;
• Gorgas-Torner, Maria Q.;
• Miarons, Marta

Publication type:

Article